Dr. Paul Kalapos, MD

Dr. Kalapos practices at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State.

Dr. Kalapos' NPI, 1932150158, was assigned on May 12, 2006. Dr. Kalapos graduated from McGill University Faculty of Medicine in 1982. Dr. Kalapos holds Pennsylvania license MD423774.

Dr. Kalapos' primary practice is Penn State Health Milton S. Hershey Medical Center, at 500 University Drive, Hershey, PA 17033 in Dauphin County. The practice phone is (717) 531-8521.

Dr. Kalapos' primary practice is Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State. Dr. Kalapos is also affiliated with Penn State Health Holy Spirit Medical Center. The medical group on file is Penn State Health Milton S. Hershey Medical Center. Dmand AI also links Dr. Kalapos to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalapos practices, 3 sites in all. Vendor and product names are available with a free account.

Neuroradiology is Dr. Kalapos' primary specialty in the NPI Registry, under taxonomy code 2085N0700X. Dr. Kalapos is board certified in diagnostic radiology by the American Board of Radiology. Dr. Kalapos is licensed in Pennsylvania.

CMS data shows 621 Medicare services from Dr. Kalapos across 21 procedure codes in 2024, for 420 Medicare patients. Medicare paid $31,452 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 420 Medicare patients who saw Dr. Kalapos in 2024. The largest group is 65 to 74, with 151 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kalapos' median patient age at 69, with 53% women.

In 2024, Dr. Kalapos wrote 28 Medicare Part D claims. 57% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $2,863 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Kalapos for performance year 2024, reported as part of a group. Dr. Kalapos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kalapos as offering telehealth.

Dmand AI links 19 papers to Dr. Kalapos, published from 2009 to 2023. 2022 was the busiest year, with 3. The most frequent topics are Magnetic Resonance Imaging, Diagnosis, Differential and Embolization, Therapeutic. Dr. Kalapos has published most often in AJNR Am J Neuroradiol. Dr. Kalapos' most frequent co-authors are Kevin M. Cockroft, MD, Krishnamoorthy Thamburaj, MD and Amit Kumar Agarwal, MD.

CMS Open Payments shows 19 general payments to Dr. Kalapos from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. Biogen, Inc. paid the most, $2,106.

Dr. Kalapos graduated from McGill University Faculty of Medicine in 1982.

Dr. Kalapos is in network with 4 carriers, including Excellus BlueCross BlueShield, Capital Blue Cross and Cigna. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.